Body Mass Index As A Prognostic Factor In HER-2 Positive Early Breast Cancer Patients And Its Effect On Duration Of Treatment With Trastuzumab: A Retrospective Study.
J Pak Med Assoc
; 73(Suppl 4)(4): S257-S262, 2023 Apr.
Article
en En
| MEDLINE
| ID: mdl-37482869
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article